Another important initiative is led by Genentech, a member of the Roche Group. The gRED program aims to discover and develop breakthrough therapies in various therapeutic areas such as oncology, immunology, neuroscience, and infectious diseases. It focuses on translating scientific research into potential life-saving treatments.